Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume

End-of-day quote Bratislava S.E.

More quotes

End-of-day quote Bratislava S.E. 29/10/2026			5-day change	1st Jan Change
33.20 ^EUR	-.--%		-.--%	+10.67%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 218M 201M 182M 345M 22.79B 355M 2.41B 958M 12.21B 912M 893M 38.59B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 217M 200M 182M 344M 22.71B 354M 2.4B 955M 12.17B 909M 890M 38.47B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Zentiva announces sale from Advent to GTCR	RE
11/09/25	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
11/09/25	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
11/09/25	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
21/02/13	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

1 month	+7.10%
3 months	+7.10%
6 months	+10.67%
Current year	+10.67%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news: Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Price Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

Quotes

1 month	31	33.2
Current year	29	33.2
1 year	29	33.2
3 years	24	45
5 years	24	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	12/11/2015
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	18/08/2022

Director	Title	Age	Since
Mojmír Krutý BRD	Director/Board Member	-	08/07/2013
Martin Albert BRD	Director/Board Member	-	18/10/2018
Kenneth Lynard BRD	Director/Board Member	58	15/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	-.--%	-.--%	-26.22%	+10.67%	60.26M
ELI LILLY AND COMPANY	+1.50%	+1.63%	+48.17%	+139.63%	1,258B
JOHNSON & JOHNSON	-0.59%	+5.40%	+48.90%	+90.53%	679B
ABBVIE INC.	-0.03%	+2.52%	+34.06%	+111.56%	518B
ROCHE HOLDING AG	+0.17%	+2.76%	+44.07%	+69.71%	390B
MERCK & CO., INC.	-0.86%	+1.90%	+69.94%	+45.40%	367B
NOVARTIS AG	+0.76%	+2.27%	+31.59%	+60.36%	307B
ASTRAZENECA PLC	-1.29%	+0.90%	+5.77%	+37.60%	293B
AMGEN INC.	-0.17%	+0.63%	+43.42%	+73.65%	252B
GILEAD SCIENCES, INC.	+0.53%	+1.65%	+44.09%	+124.24%	210B
Average	+0.06%	+1.95%	+34.38%	+76.34%	427B
Weighted average by Cap.	+0.31%	+1.33%	+43.49%	+96.63%

	2017	2018
Net sales	143M 128M 118M 107M 203M 13.38B 208M 1.41B 563M 7.17B 535M 524M 22.66B	36.17M 32.44M 29.9M 27.15M 51.39M 3.39B 52.82M 358M 143M 1.82B 136M 133M 5.74B
Net income	77.98M 69.93M 64.45M 58.53M 111M 7.31B 114M 772M 307M 3.92B 293M 286M 12.38B	2.29M 2.05M 1.89M 1.72M 3.25M 215M 3.34M 22.66M 9.03M 115M 8.59M 8.41M 364M
Net Debt	-0.09 -0.08 -0.08 -0.07 -0.13 -8.63 -0.13 -0.91 -0.36 -4.62 -0.35 -0.34 -14.61	-0.77 -0.69 -0.64 -0.58 -1.1 -72.57 -1.13 -7.66 -3.05 -38.88 -2.9 -2.84 -122.91